Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
Study sponsor: Tarsus Pharmaceuticals, Inc. · TARS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-12-31Estimated
Enrollment · participants155Estimated
Source updated2026-03-02Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.